Clinical Trial Update: Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of mini-dose glucagon (G-Pen Mini) for treating hypoglycemia in patients with type 1 diabetes; results were posted on 2016-05-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• G-Pen Mini (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2016-05-16